SOFTWAY MEDICAL SERVICES : revenue, balance sheet and financial ratios

SOFTWAY MEDICAL SERVICES is a French company founded 38 years ago, specialized in the sector Tierce maintenance de systèmes et d’applications informatiques. Based in FUVEAU (13710), this company of category ETI shows in 2024 a revenue of 74.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SOFTWAY MEDICAL SERVICES (SIREN 342434156)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 74 486 339 € 67 028 341 € 54 469 445 € 44 434 492 € 33 491 523 € 35 233 478 € 30 032 715 € 26 773 108 € 23 069 787 €
Net income 4 645 693 € 4 440 616 € 3 456 213 € 1 740 754 € 1 288 115 € 356 743 € 604 732 € 726 817 € 449 617 €
EBITDA 5 195 821 € 7 134 225 € 5 008 903 € 2 650 056 € 1 865 668 € 613 439 € 954 855 € 1 297 617 € 771 333 €
Net margin 6.2% 6.6% 6.3% 3.9% 3.8% 1.0% 2.0% 2.7% 1.9%

Revenue and income statement

In 2024, SOFTWAY MEDICAL SERVICES achieves revenue of 74.5 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +15.8%. Vs 2023, growth of +11% (67.0 M€ -> 74.5 M€). After deducting consumption (1.3 M€), gross margin stands at 73.2 M€, i.e. a rate of 98%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 5.2 M€, representing 7.0% of revenue. Warning negative scissor effect: despite revenue change (+11%), EBITDA varies by -27%, reducing margin by 3.7 pts. This reflects costs rising faster than revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 4.6 M€, i.e. 6.2% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

74 486 339 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

73 177 572 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

5 195 821 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

5 609 820 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

4 645 693 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

7.0%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 27%. The balance between equity and debt is satisfactory. Cash flow represents 6.0% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

26.612%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

5.97%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

23.7%

Solvency indicators evolution
SOFTWAY MEDICAL SERVICES

Sector positioning

Debt ratio
0.0 2024
2022
2023
2024
Q1: 0.0
Med: 6.26
Q3: 31.65
Excellent

In 2024, the debt ratio of SOFTWAY MEDICAL SERVICES (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
26.61% 2024
2022
2023
2024
Q1: 10.26%
Med: 37.66%
Q3: 64.72%
Average +15 pts over 3 years

In 2024, the financial autonomy of SOFTWAY MEDICAL SERVICES (26.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
0.0 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 0.37 years
Excellent

In 2024, the repayment capacity of SOFTWAY MEDICAL SERVICES (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 158.38. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 13.8x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

158.376

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

13.763

Liquidity indicators evolution
SOFTWAY MEDICAL SERVICES

Sector positioning

Liquidity ratio
158.38 2024
2022
2023
2024
Q1: 148.11
Med: 236.84
Q3: 413.51
Average

In 2024, the liquidity ratio of SOFTWAY MEDICAL SERVICES (158.38) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
13.76x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.0x
Q3: 1.49x
Excellent

In 2024, the interest coverage of SOFTWAY MEDICAL SERVICES (13.8x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 109 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 126 days. Favorable situation: supplier credit is longer than customer credit by 17 days. Overall, WCR represents 151 days of revenue, i.e. 31.3 M€ to permanently finance. Over 2016-2024, WCR increased by +195%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

31 280 538 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

109 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

126 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

151 j

WCR and payment terms evolution
SOFTWAY MEDICAL SERVICES

Positioning of SOFTWAY MEDICAL SERVICES in its sector

Comparison with sector Tierce maintenance de systèmes et d’applications informatiques

Valuation estimate

Based on 215 transactions of similar company sales (all years), the value of SOFTWAY MEDICAL SERVICES is estimated at 7 494 782 € (range 3 474 614€ - 21 788 500€). With an EBITDA of 5 195 821€, the sector multiple of 1.0x is applied. The price/revenue ratio is 0.16x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
215 transactions
3474k€ 7494k€ 21788k€
7 494 782 € Range: 3 474 614€ - 21 788 500€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
5 195 821 € × 1.0x
Estimation 5 074 494 €
1 916 655€ - 22 425 469€
Revenue Multiple 30%
74 486 339 € × 0.16x
Estimation 11 956 074 €
6 413 241€ - 21 839 615€
Net Income Multiple 20%
4 645 693 € × 1.5x
Estimation 6 853 569 €
2 961 575€ - 20 119 407€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Tierce maintenance de systèmes et d’applications informatiques)

Compare SOFTWAY MEDICAL SERVICES with other companies in the same sector:

Voir toutes les statistiques du secteur Tierce maintenance de systèmes et d’applications informatiques

Frequently asked questions about SOFTWAY MEDICAL SERVICES

What is the revenue of SOFTWAY MEDICAL SERVICES ?

The revenue of SOFTWAY MEDICAL SERVICES in 2024 is 74.5 M€.

Is SOFTWAY MEDICAL SERVICES profitable?

Yes, SOFTWAY MEDICAL SERVICES generated a net profit of 4.6 M€ in 2024.

Where is the headquarters of SOFTWAY MEDICAL SERVICES ?

The headquarters of SOFTWAY MEDICAL SERVICES is located in FUVEAU (13710), in the department Bouches-du-Rhone.

Where to find the tax return of SOFTWAY MEDICAL SERVICES ?

The tax return of SOFTWAY MEDICAL SERVICES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SOFTWAY MEDICAL SERVICES operate?

SOFTWAY MEDICAL SERVICES operates in the sector Tierce maintenance de systèmes et d’applications informatiques (NAF code 62.02B). See the 'Sector positioning' section above to compare the company with its competitors.